transfer to a surrogate is an option, if available, for patients with severe disease-related damage who desire a biologic child and are able to undergo ovarian stimulation and oocyte retrieval, but cannot safely undergo pregnancy. We strongly recommend continuation of necessary immunosuppressive and/or biologic therapies (except CYC, which directly impacts maturing follicles) in treated patients whose condition is stable, when the purpose of ovarian stimulation is oocyte retrieval for oocyte or